fibrinogen has been researched along with Insulin Resistance in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.51) | 18.7374 |
| 1990's | 32 (16.41) | 18.2507 |
| 2000's | 92 (47.18) | 29.6817 |
| 2010's | 56 (28.72) | 24.3611 |
| 2020's | 14 (7.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, L; Liang, H; Yang, X; Yao, J; Zhang, Z; Zhou, W | 1 |
| Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y | 1 |
| Kowalcze, K; Krysiak, R; Okopień, B | 4 |
| Basiak, M; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Furr, M; Jayathilake, WMNK; Lacombe, VA; Risco, C | 1 |
| Atkin, SL; Butler, AE; Moin, ASM; Sathyapalan, T | 2 |
| Amini, A; Arabzadeh, E; Avazpour, S; Shirvani, H | 1 |
| Alama, MN; Jabir, NR; Shakil, S; Tabrez, S | 1 |
| Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Barquero-Perez, O; Garcia-Carretero, R; Vigil-Medina, L | 1 |
| Ajjan, RA; Campbell, MD; Holmes, M; Kietsiriroje, N; O'Mahoney, LL; Pearson, S; West, DJ | 1 |
| Guallar-Castillón, P; Gutierrez-Fisac, JL; Laclaustra, M; León-Muñoz, LM; Lopez-Garcia, E; Pérez-Tasigchana, RF; Rodríguez-Artalejo, F | 1 |
| Andreozzi, F; Fiorentino, TV; Mannino, GC; Marini, MA; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G | 1 |
| Bazinet, RP; Festa, A; Haffner, SM; Hanley, AJ; Liese, AD; Lorenzo, C; Rewers, MJ; Santaren, ID; Wagenknecht, LE; Watkins, SM | 1 |
| Abd El-Aty, AM; Chung, YH; Jeong, JH; Jung, TW; Kim, HC | 1 |
| Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M | 1 |
| Milošević, I; Perčić, I; Stokić, E; Tomić Naglić, D; Urošević, I | 1 |
| Bjekić-Macut, J; Bojanin, D; Djukić, T; Macut, D; Mastorakos, G; Mažibrada, I; Perović, S; Plavšić, L; Plješa-Ercegovac, M; Savić-Radojević, A; Simić, PD; Simić, T | 1 |
| Azadbakht, L; Larijani, B; Mozaffari, H; Namazi, N; Surkan, PJ | 1 |
| Krysiak, R; Marek, B; Okopień, B | 1 |
| Balagopal, PB; Farrell, DH; George, D; Hossain, J; Komakula, V; Lovely, R; Ramsey, JP | 1 |
| Charlton, MR; Gawrieh, S; Guichelaar, MM; Krishnan, A; Malinchoc, M; Olivier, M; Sanderson, S; Sarr, M; Swain, JM; Viker, K; Watt, KD | 1 |
| Tarango, C; Ware, RE | 1 |
| Gdula-Dymek, A; Krysiak, R; Okopień, B | 1 |
| Dagnelie, PC; Derom, C; Gerver, WJ; Gielen, M; Houben, AJ; Loos, RJ; Mulder, AL; Stehouwer, CD; Touwslager, RN; Vlietinck, R; Zeegers, MP; Zimmermann, LJ | 1 |
| Chan, C; Green, D; Kanaya, AM; Klein, OL; Liu, K; Okwuosa, T; Schreiner, P | 1 |
| Galán, I; Guallar-Castillón, P; Rodríguez-Artalejo, F; Valencia-Martín, JL | 1 |
| Becerril, S; Catalán, V; Fernández, S; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Lancha, A; Méndez-Giménez, L; Moncada, R; Ramírez, B; Rodríguez, A; Rotellar, F; Salvador, J; Valentí, V | 1 |
| Aryan, Z; Esteghamati, A; Nakhjavani, M | 1 |
| Artenisio, AC; Benvenga, S; Borrielli, I; Bruno, LM; Giunta, L; La Marca, A; Pizzo, A; Stabile, G; Volpe, A | 1 |
| Danışman, N; Engin-Üstün, Y; Katar, C; Özyer, Ş; Uzunlar, Ö | 1 |
| Cohen, BE; Jarvie, JL; Regan, MC; Sin, NL; Whooley, MA | 1 |
| Avgoustinaki, PD; Bardos, AN; Dermitzaki, E; Margioris, AN; Simos, P; Spyridaki, EC; Venihaki, M | 1 |
| Brite, J; Dowd, JB; McCrillis, AM; Reales, D; Romo, ML; Schooling, CM | 1 |
| Bozic, J; Dogas, Z; Galic, T; Gunjaca, G; Ivkovic, N; Ticinovic, TK | 1 |
| Abu-Farha, M; Abubaker, J; Al-Khairi, I; Behbehani, K; Cherian, P; Elkum, N; Hu, FB; Noronha, F | 1 |
| Bagir, GS; Bakiner, OS; Bozkirli, E; Cavlak, G; Ertorer, ME; Serinsoz, H | 1 |
| Agudo-Conde, C; de Cabo Laso, A; de la Fuente, Ade L; Garcia-Ortiz, L; Gomez-Marcos, MA; Maderuelo-Fernandez, JA; Mendizabal-Gallastegui, N; Notario-Pacheco, B; Otegui-Ilarduya, L; Patino-Alonso, MC; Puigdomenech, E; Recio-Rodriguez, JI | 1 |
| Aragno, M; Costelli, P; De Stefanis, D; Mastrocola, R; Nigro, D | 1 |
| Chang, CJ; Hung, HC; Lu, FH; Ou, HY; Su, YC; Wu, CL; Wu, HT; Wu, JS; Yang, YC | 1 |
| Adamovski, M; Bernal, RT; da Silva, NN; Debortoli, G; Gonçalves, Mde C; Mastroeni, MF; Mastroeni, SS; Rondó, PH; Veugelers, PJ | 1 |
| An, JH; Kim, DL; Kim, SK; Song, KH | 1 |
| Albayrak, S; Can, G; Erbilen, E; Hergenç, G; Keleş, I; Küçükdurmaz, Z; Onat, A; Ozhan, H | 1 |
| Liese, AD; Schulz, M; Tooze, JA; Weis, KE | 1 |
| Oztekin, K; Sahin, F; Saraç, F; Saydam, G; Saygili, F; Tüzün, M; Yilmaz, C | 1 |
| Anuurad, E; Berglund, L; Kim, K; Pearson, TA; Tracy, RP | 1 |
| Araujo de Baptista, E; Baptista, T; Beaulieu, S; El Fakih, Y; Galeazzi, T; Rangel, N; Uzcátegui, E | 1 |
| Bruehl, H; Convit, A; Javier, E; Lee, C; Reddy, S; Sweat, V; Tirsi, A; Tsui, W | 1 |
| Karatela, RA; Sainani, GS | 1 |
| Akinci, B; Comlekci, A; Demir, T; Ertilav, S; Secil, M; Yener, S; Yesil, S | 1 |
| Binici, DN; Borazan, A | 1 |
| Bi, Z; Dong, J; Fu, Z; Guo, X; Jia, C; Liu, L; Ma, J; Su, J; Xu, A | 1 |
| Cho, BJ; Choi, SH; Han, DS; Han, SH; Jang, HC; Kang, SW; Kim, YB; Lee, HK; Lee, Y; Lim, S; Moon, MK; Park, KS; Park, YJ | 1 |
| Bonura, F; Caccamo, G; Evola, G; Evola, S; Grisanti, MR; Novo, G; Novo, S; Vitale, G | 1 |
| Fritsch, M; Fritsch, P; Kleber, M; Mangge, H; Muntean, W; Reinehr, T; Rosenkranz, A | 1 |
| Akyol, A; Kadikoylu, G; Kiylioglu, N; Ozkul, A; Tataroglu, C; Turgut, ET; Yenisey, C | 1 |
| He, K; Jacobs, DR; Kim, DJ; Liu, K; Loria, C; Xun, P; Yokota, K | 1 |
| Cao, H; Hotamisligil, GS; King, IB; Lemaitre, RN; Mozaffarian, D; Siscovick, DS; Song, X | 1 |
| Bergholm, R; Hakkarainen, A; Joutsi-Korhonen, L; Kotronen, A; Lassila, R; Lundbom, N; Pietiläinen, KH; Rissanen, A; Sevastianova, K; Yki-Järvinen, H | 1 |
| Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R | 1 |
| Belson, L; Berthiaume, Y; Coderre, L; Malet, A; Rabasa-Lhoret, R; Tardif, A; Ziai, S | 1 |
| Hamsten, A; Joutsi-Korhonen, L; Kaprio, J; Kaye, SM; Kotronen, A; Lassila, R; Pietiläinen, KH; Rissanen, A; Silveira, A; Yki-Järvinen, H | 1 |
| Arvanitidou, M; Galli-Tsinopoulou, A; Haidich, AB; Kyrgios, I; Papakonstantinou, E; Stylianou, C | 1 |
| Han, SH; Koh, KK; Lee, K; Lee, Y; Lim, S; Quon, MJ; Sakuma, I; Shin, EK; Shin, KC | 1 |
| Baghaei, F; Holm, G; Janson, PO; Lönn, M; Mannerås-Holm, L; Olivecrona, G; Stener-Victorin, E | 1 |
| Abbasi, F; Malhotra, D; Mathur, A; Molina, CR; Reaven, GM | 1 |
| Athanasiadou, Z; Fotiadis, G; Kadoglou, NP; Lampropoulos, S; Vitta, I; Vrabas, IS | 1 |
| Combescure, C; de Moerloose, P; Dirlewanger, MA; Meier, CA; Reber, G; Roux-Lombard, P; Saudan, S; Schwitzgebel, VM; Stoppa-Vaucher, S | 1 |
| Krysiak, R; Okopien, B | 1 |
| Baer, DJ; Clevidence, BA; Henderson, T; Novotny, JA; Radecki, SV; Stote, KS | 1 |
| Breza, J; Goncalves, FM; Ziaran, S | 1 |
| Festa, A; Goodarzi, MO; Haffner, SM; Hanley, AJ; Lee, CC; Lorenzo, C; Norris, JM; Olson, NC; Rewers, MJ; Stefanovski, D; Wagenknecht, LE | 1 |
| Capaldo, B; de Simone, G; Devereux, RB; Di Bonito, P; Howard, BV; Iaccarino, M; Lee, ET; Riccardi, G; Roman, MJ | 1 |
| Aversa, A; Bruzziches, R; Donini, LM; Francomano, D; Greco, EA; Lenzi, A; Violi, F | 1 |
| Mertens, I; Van Gaal, LF | 1 |
| Cienfuegos, JA; de Irala, J; Diez-Caballero, A; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Orbe, J; Páramo, JA; Salvador, J | 1 |
| Brown, NJ; Hopkins, PN; Hunt, SC; Jeunemaitre, X; Srikumar, N; Vaughan, DE; Williams, GH | 1 |
| Damsgaard, EM; Foss, CH; Frøland, A; Gjessing, HJ; Ingerslev, J; Mogensen, CE; Vestbo, E | 1 |
| Biondi, B; Fazio, S; Lombardi, G; Nuzzo, V; Palmieri, EA; Pulcrano, M; Rossi, R; Tauchmanovà, L | 1 |
| Fukushima, M; Kuroe, A; Nagasaka, S; Nakai, Y; Nin, K; Ogura, M; Okumura, T; Sakai, M; Seino, Y; Taniguchi, A; Watanabe, T; Yamada, Y; Yamadori, N; Yoshii, S | 1 |
| Gilardini, L; Guzzaloni, G; Invitti, C; Morabito, F; Viberti, G | 1 |
| Klatsky, AL | 1 |
| Chen, JF; Li, CP; Pen, M | 1 |
| Festa, A; Kopp, CW; Kopp, HP; Kriwanek, S; Krzyzanowska, K; Minar, E; Roka, R; Schernthaner, G | 1 |
| Brekke, H; Funahashi, T; Jansson, PA; Matsuzawa, Y; Pellmé, F; Smith, U; Taskinen, MR; Wiklund, O | 1 |
| Imai, Y; Nagai, R | 1 |
| Lip, GY; Marín, F; Roldán, V | 1 |
| Grant, PJ | 2 |
| Aillaud, MF; Alessi, MC; Aubert, H; Frère, C; Juhan-Vague, I; Morange, PE | 1 |
| Akalin, S; Akpinar, I; Deyneli, O; Gözü, H; Haklar, G; Sezgin, O; Yavuz, D; Yildiz, E | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Hanley, AJ; Tracy, RP | 1 |
| Hans, M; Juhan-Vague, I | 1 |
| Derby, C; Jannausch, ML; Pasternak, R; Sowers, M; Torrens, JI | 1 |
| Cowan, D; Kaski, JC; Sidhu, JS | 1 |
| Berg, C; Herrmann, BL; Mann, K; Nowak, T; Renzing-Koehler, K; Saller, B; Vogel, E | 1 |
| Alessi, MC; Juhan-Vague, I; Morange, PE | 1 |
| Ikeda, T; Kobayashi, S; Kumagai, H; Moriya, H; Ohtake, T | 1 |
| Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD | 1 |
| Celińska-Löwenhoff, M; Undas, A | 1 |
| Barud, W; Hanzlik, J; Makaruk, B; Palusiński, R | 1 |
| Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A | 1 |
| Dobordzhginidze, LM | 1 |
| Crook, D; Godsland, IF; Proudler, AJ; Stevenson, JC | 1 |
| Altun, A; Tatli, E; Tugrul, A; Ugur-Altun, B | 1 |
| Bergeron, J; Corneau, L; Lemieux, S; Nadeau, A; Piché, ME; Weisnagel, SJ | 1 |
| Araki, T; Emoto, M; Fujiwara, S; Hatsuda, S; Koyama, H; Maeno, T; Nishizawa, Y; Shinohara, K; Shoji, T; Tahara, H; Yokoyama, H | 1 |
| Steinberger, J | 1 |
| Balagopal, P; Bayne, E; George, D; Gidding, S; Patton, N; Roberts, WL; Yarandi, H | 1 |
| Dunn, EJ; Grant, PJ | 1 |
| Altun, A; Gerenli, M; Tugrul, A; Ugur-Altun, B | 1 |
| Bertolini, L; Falezza, G; Scala, L; Targher, G; Zenari, L; Zoppini, G | 1 |
| Day, IN; Ebrahim, S; Lawlor, DA; Smith, GD; Timpson, N | 1 |
| den Boer, MA; Havekes, LM; Korsheninnikova, E; Kuipers, F; Ouwens, DM; Romijn, JA; Schröder-van der Elst, JP; Voshol, PJ | 1 |
| Cienfuegos, JA; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Pastor, C; Rotellar, F; Salvador, J; Silva, C | 1 |
| Huisman, HW; Malan, L; Malan, NT; Schutte, AE; Schutte, R; van Rooyen, JM; van Vuuren, D | 1 |
| Franks, PW | 1 |
| Freed, MI; Haffner, SM; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; O'Neill, MC; Viberti, GC; Yu, D; Zinman, B | 1 |
| Asplund, K; Birgander, LS; Burell, G; Claesson, M; Jansson, JH; Lindahl, B; Mattsson, C | 1 |
| Aktürk, M; Altinova, AE; Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Törüner, FB | 1 |
| Andrade, CD; de Bittencourt, PI; Nácul, AP; Schwarz, P; Spritzer, PM | 1 |
| Huisman, HW; Malan, L; Malan, NT; Schutte, AE; Schutte, R; van Rooyen, JM | 1 |
| Baptista, T; Beaulieu, S; Contreras, Q; de Mendoza, S; Galeazzi, T; Lacruz, A; Rangel, N; Sandia, I; Vargas, D | 1 |
| Fuerbringer, R; Gonçalves, LF; Leinig, C; Lindholm, B; Martins, C; Mazza do Nascimento, M; Pecoits-Filho, R; Riella, MC; Stenvinkel, P | 1 |
| Caringella, M; Coviello, M; De Pergola, G; Di Roma, P; Giorgino, R; Pannacciulli, N; Quaranta, M; Scarangella, A; Venneri, MT | 1 |
| Boreham, CA; Ferreira, I; Gallagher, AM; Murray, LJ; Stehouwer, CD; Twisk, JW; Young, IS | 1 |
| Corella, D; España, F; Estellés, A; Hernández-Mijares, A; Santaolaria, ML; Solá, E; Vayá, A | 1 |
| Corella, D; España, F; Estellés, A; Hernández-Mijares, A; Morillas, C; Simó, M; Solá, E; Vayá, A | 1 |
| Ahmad, I; Ahmad, J; Ahmned, F; Hameed, B; Katyal, P; Khan, AR; Siddiqui, MA | 1 |
| Barzilay, JI; Chaves, PH; Domitrovich, PP; Gottdiener, JS; Heckbert, SR; Stein, PK; Traber, J | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Suarez, EC | 1 |
| Bertolini, L; Day, CP; Franchini, M; Lippi, G; Muggeo, M; Rodella, S; Targher, G; Zoppini, G | 1 |
| Alper, GE; Cağlayan, O; Erdoğan, M; Karadeniz, M; Saygili, F; Tamsel, S; Yilmaz, C; Zengi, A | 1 |
| Battaglia, C; Cianciosi, A; de Aloysio, D; Facchinetti, F; Mancini, F; Reggiani, GM | 1 |
| Avcu, F; Dogru, T; Erdem, G; Erikci, S; Genc, H; Kilic, S; Savasci, S; Sonmez, A; Tasci, I; Ural, AU | 1 |
| Bub, A; Hahn, A; Hülsmann, O; Kressel, G; Lichtinghagen, R; Stichtenoth, DO; Trunz, B; Wolters, M | 1 |
| Alfenas, Rde C; Bressan, J; Costa, NM; Minim, VP; Stringueta, PC; Volp, AC | 1 |
| Topinka, V; Válek, J; Válková, L; Vlasáková, Z | 1 |
| McCarty, MF | 1 |
| Koschyk, DH; Langes, K; Nienaber, CA; Rinninger, F; Schneider, MA; Volk, C | 1 |
| Abdelnoor, M; Andersen, P; Arnesen, H; Birkeland, K; Dale, PO; Løvik, A; Seljeflot, I | 1 |
| Boucher, L; Cozic, JA; Gorlier, R; Huin, P; Pettenuzzo-Mollo, M; Provendier, O; Raccah, D; Sicard, J; Vague, P | 1 |
| Birkeland, KI; Kjeldsen, SE; Moan, A; Nordby, G; Os, I | 1 |
| Barker, DJ | 1 |
| Jespersen, J; Juhan-Vague, I; Thompson, SG | 1 |
| Koschyk, DH; Langes, K; Meinertz, T; Nienaber, CA; Rinninger, F; Schneider, MA; Volk, C | 1 |
| Grant, PJ; Heywood, DM; Mansfield, MW | 1 |
| Brun, JF; Kabbaj, H; Monnier, JF; Orsetti, A | 1 |
| Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A | 1 |
| Eliasson, B; Mero, N; Smith, U; Taskinen, MR | 1 |
| Barradell, LB; Goa, KL; Plosker, GL | 1 |
| Bloch, J; Chevenne, D; Collin, D; Czernichow, P; Leger, J; Levy-Marchal, C; Pinet, A; Porquet, D | 1 |
| Alberti, KG; Brunner, EJ; Juneja, M; Marmot, MG; Nanchahal, K; Shipley, MJ; Stansfeld, SA | 1 |
| Imperatore, G; Iovine, C; Riccardi, G; Rivellese, AA; Vaccaro, O | 1 |
| Brun, JF; Orsetti, A; Perez-Martin, A; Raynaud, E; Solère, M | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Brun, JF; Mercier, J; Perez-Martin, A; Raynaud, E | 1 |
| Desaive, C; Dewe, W; Gielen, JE; Lefebvre, PJ; Luyckx, FH; Scheen, AJ | 1 |
| Alessi, MC; Juhan-Vague, I; Morange, P; Renucci, JF | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Hales, CN; Mykkänen, L; Tracy, RP; Zaccaro, DJ | 1 |
| Yudkin, JS | 1 |
| Ahrén, B; Eliasson, M; Johnson, O; Olsson, T; Söderberg, S | 1 |
| Bowen, K; Campbell, L; Lintott, CJ; Scott, R; Welborn, T; Zimmet, P | 1 |
| Balkau, B; Charles, MA; D'Hour, A; le Mauff, JM; Mennen, LI | 1 |
| Arakawa, K; Saku, K; Shirai, K; Takezako, T; Zhang, B | 1 |
| Horsten, M; Mittleman, MA; Orth-Gomér, K; Schenck-Gustafsson, K; Wamala, SP | 1 |
| Aïssa-Benhaddad, A; Brun, J; Fédou, C; Mercier, J; Pérez-Martin, A; Raynaud, E | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Howard, G; Mykkänen, L; Tracy, RP | 2 |
| Marckmann, P | 1 |
| Bengtsson, BA | 1 |
| Bell, DS | 1 |
| Cushman, M; Lewis, MR; Sakkinen, PA; Tracy, RP; Wahl, P | 1 |
| Aldington, SJ; Chaturvedi, N; Fuller, JH; Kohner, EM; Porta, M; Sjoelie, AK; Songini, M | 1 |
| Aso, Y; Fujiwara, Y; Inukai, T; Takanashi, K; Takemura, Y; Tayama, K | 1 |
| Best, JD; Cumpston, GN; Dragicevic, G; Giles, GG; Herbert, KE; O'Dea, K; Stoney, RM | 1 |
| Halonen, P; Kareinen, A; Laakso, M; Lehto, S; Viitanen, L | 1 |
| Fiévet, C; Holmes, MC; Morton, NM; Mullins, JJ; Seckl, JR; Staels, B; Tailleux, A | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Karter, AJ; Mayer-Davis, EJ; Tracy, RP; Williams, K | 1 |
| Aguilar-Salinas, CA; Cesarman, G; Chavira-López, IJ; Fanghänel-Salmón, G; Gallegos-Martínez, J; Gómez-Diaz, RA; Gómez-Pérez, FJ; Guillén, LE; López, A; Salinas-Orozco, S; Sánchez-Reyes, L; Tamez, R; Torres-Acosta, EM; Vázquez-Chávez, C | 1 |
| Brun, JF; Dumortier, M; Mercier, J; Pérez-Martin, A; Pierrisnard, E; Raynaud, E | 1 |
| Jonkers, IJ; Mohrschladt, MF; Smelt, AH; van der Laarse, A; Westendorp, RG | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Tracy, RP | 1 |
| Grant, PJ; Mansfield, MW; Mills, JD | 1 |
| Bratt, G; Bylund, H; Koppel, K; Sandström, E; Schulman, S | 1 |
| Bergmann, S; Hanefeld, M; Henkel, E; Jaross, W; Koehler, C; Siegert, G; Temelkova-Kurktschiev, T | 1 |
| Bamford, J; Bavington, J; Catto, AJ; Grant, PJ; Kain, K; Young, J | 1 |
| Ellis, D; Orchard, TJ; Stuhldreher, WL | 1 |
| Landin, K; Smith, U; Tengborn, L | 1 |
| Levine, LS; New, MI; Sonenberg, M | 1 |
17 review(s) available for fibrinogen and Insulin Resistance
| Article | Year |
|---|---|
Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review.
Topics: Adiposity; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Fibrinogen; Humans; Hypertension; Insulin Resistance; Male; Prostatic Neoplasms; Risk Factors; Triglycerides | 2015 |
Obesity, haemostasis and the fibrinolytic system.
Topics: Blood Coagulation Factors; Body Constitution; Cardiovascular Diseases; Factor VII; Factor VIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Obesity; Plasminogen Activator Inhibitor 1; von Willebrand Factor; Weight Loss | 2002 |
[New biochemical and genetic risk factors for coronary artery diseases].
Topics: Aryldialkylphosphatase; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Coronary Artery Disease; Esterases; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Lipoproteins, LDL; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors | 2003 |
Fibrinolytic function and atrial fibrillation.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Insulin Resistance; Matrix Metalloproteinases; Plasminogen; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Tissue Plasminogen Activator | 2003 |
The genetics of atherothrombotic disorders: a clinician's view.
Topics: Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Factor VII; Factor XII; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Inflammation; Insulin Resistance; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2003 |
[From fibrinogen to fibrin and its dissolution].
Topics: Animals; Arteriosclerosis; Carboxypeptidase B2; Cell Movement; Diabetes Mellitus; Disease Models, Animal; Endothelial Cells; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Metalloproteases; Mice; Mice, Transgenic; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin; Thrombosis; Wound Healing | 2003 |
Relations between hemostatic variables, insulin resistance and inflammation.
Topics: Adipose Tissue; Adult; Aged; C-Reactive Protein; Cohort Studies; Cytokines; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Thrombophilia; von Willebrand Factor | 2004 |
[Nonlipid effects of fibrates].
Topics: C-Reactive Protein; Cytokines; Fibrinogen; Homocysteine; Humans; Hypolipidemic Agents; Insulin Resistance; Intercellular Adhesion Molecule-1; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2004 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Type 2 diabetes: an atherothrombotic syndrome.
Topics: Animals; Blood Coagulation; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Factor VIII; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Plasminogen Activator Inhibitor 1; Syndrome; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2005 |
Diabetes mellitus as a prothrombotic condition.
Topics: Blood Coagulation Factors; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Insulin Resistance; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 2007 |
[Inflammation biomarkers capacity in predicting the metabolic syndrome].
Topics: Adipokines; Biomarkers; C-Reactive Protein; Chemokines; Cytokines; Fibrinogen; Humans; Inflammation Mediators; Insulin Resistance; Metabolic Syndrome; Obesity; Predictive Value of Tests; Serum Amyloid A Protein | 2008 |
The intrauterine origins of cardiovascular disease.
Topics: Adult; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Infant, Newborn; Insulin; Insulin Resistance; Lipids; Male; Maternal Welfare; Middle Aged; Nutritional Physiological Phenomena | 1993 |
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction | 1996 |
Fibrinogen, obesity and insulin resistance.
Topics: Female; Fibrinogen; Humans; Insulin Resistance; Male; Obesity; Plasminogen Activator Inhibitor 1; Risk Factors | 1999 |
Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Fibrinolysis; Humans; Insulin Resistance; Risk Factors; von Willebrand Factor | 1999 |
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
Topics: Coronary Disease; Cross-Sectional Studies; Diet, Fat-Restricted; Dietary Fiber; Factor VII; Fibrinogen; Humans; Insulin; Insulin Resistance; Obesity; Thrombosis; Triglycerides | 2000 |
27 trial(s) available for fibrinogen and Insulin Resistance
| Article | Year |
|---|---|
Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis.
Topics: Adult; Biomarkers; Blood Coagulation; Blood Glucose; Body Mass Index; Cluster Analysis; Diabetes Mellitus, Type 1; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Assessment; Thromboplastin; Thrombosis | 2021 |
Obesity-related increased γ' fibrinogen concentration in children and its reduction by a physical activity-based lifestyle intervention: a randomized controlled study.
Topics: Adiposity; Adolescent; Cardiovascular Diseases; Exercise; Female; Fibrinogen; Humans; Insulin Resistance; Life Style; Male; Motor Activity; Obesity; Risk Factors | 2013 |
Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.
Topics: Dose-Response Relationship, Drug; Drug Synergism; Female; Fenofibrate; Fibrinogen; Glucose Intolerance; Hemostasis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Single-Blind Method | 2013 |
Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Topics: Adiponectin; Adolescent; C-Reactive Protein; Female; Fibrinogen; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Menstrual Cycle; Menstruation Disturbances; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones; Young Adult | 2014 |
Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Double-Blind Method; Female; Fibrinogen; Hemoglobins; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pilot Projects; Rosiglitazone; Schizophrenia; Statistics as Topic; Thiazolidinediones | 2009 |
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator | 2011 |
Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.
Topics: Adiponectin; Analysis of Variance; Apolipoprotein A-I; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Dietary Supplements; Fatty Acids, Omega-3; Female; Fenofibrate; Fibrinogen; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Male; Middle Aged; Republic of Korea; Single-Blind Method; Time Factors; Treatment Outcome; Triglycerides; Vasodilation | 2012 |
Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
Topics: Adipocytes; Adult; Biomarkers; Blood Coagulation; Blood Pressure; Electroacupuncture; Exercise Therapy; Female; Fibrinogen; Fibrinolysis; Heart Rate; Humans; Insulin Resistance; Lipoprotein Lipase; Oxygen Consumption; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Prospective Studies; Subcutaneous Fat, Abdominal; Sweden; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2012 |
The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
Topics: Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Lipids; Lipoprotein(a); Male; Middle Aged; Resistance Training; Respiratory Function Tests; Waist-Hip Ratio | 2012 |
Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose.
Topics: Antigens; Blood Coagulation; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Factor VII; Fasting; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Simvastatin | 2012 |
Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Beverages; Biomarkers; Body Mass Index; Cacao; Cross-Over Studies; District of Columbia; Double-Blind Method; Female; Fibrinogen; Flavonols; Hemostasis; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Overweight; Oxidative Stress; Tea | 2012 |
Weight loss by multidisciplinary intervention improves endothelial and sexual function in obese fertile women.
Topics: Absorptiometry, Photon; Adolescent; Adult; Ambulatory Care; Body Composition; C-Reactive Protein; Diet, Reducing; Endothelium, Vascular; Exercise; Female; Fibrinogen; Health Behavior; Hospitalization; Humans; Insulin; Insulin Resistance; Life Style; Middle Aged; Obesity; Outpatient Clinics, Hospital; Patient Care Team; Premenopause; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Weight Loss; Young Adult | 2013 |
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Topics: Adult; Blood Glucose; Bromocriptine; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Estrogens; Female; Fibrinogen; Glucose Tolerance Test; Homocysteine; Hormone Antagonists; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Premenopause; Prolactin; Uric Acid; Vasodilation | 2003 |
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Vasodilator Agents | 2003 |
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Topics: Aged; Arginine; Blood Glucose; Blood Pressure; Body Composition; Body Constitution; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Placebos; Testosterone | 2004 |
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States | 2004 |
Dihydrotestosterone treatment in men with coronary artery disease. I. Influence on sex hormones, lipid profile, insulin resistance and fibrinogen.
Topics: Administration, Topical; Aging; Androgens; Coronary Artery Disease; Dihydrotestosterone; Estradiol; Fibrinogen; Gonadal Steroid Hormones; Humans; Insulin Resistance; Lipoproteins; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2003 |
Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents.
Topics: Adolescent; Analysis of Variance; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diet, Fat-Restricted; Discriminant Analysis; Exercise; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Interleukin-6; Life Style; Male; Obesity; Risk Factors; Time Factors | 2005 |
Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.
Topics: Biomarkers; C-Reactive Protein; Cognitive Behavioral Therapy; Female; Fibrinogen; Humans; Insulin Resistance; Leptin; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Stress, Psychological; Tissue Plasminogen Activator; von Willebrand Factor | 2006 |
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; C-Reactive Protein; Double-Blind Method; Female; Fibrinogen; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metformin; Middle Aged; Olanzapine; Schizophrenia; Sex Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Female; Fibrinogen; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Obesity; Piperazines; Tetrazoles | 2008 |
Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.
Topics: Adult; Aged; Antigens; Blood Pressure; Captopril; Double-Blind Method; Factor VII; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Nicardipine; Obesity; Radioimmunoassay; Risk Factors | 1994 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
Topics: Acarbose; Adult; Aged; Area Under Curve; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged; Proinsulin; Random Allocation; Triglycerides; Trisaccharides | 1999 |
Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution.
Topics: Aged; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
Topics: Bezafibrate; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Lipids; Male; Middle Aged; Tumor Necrosis Factor-alpha | 2002 |
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
Topics: Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; C-Reactive Protein; Causality; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Risk Factors | 2002 |
151 other study(ies) available for fibrinogen and Insulin Resistance
| Article | Year |
|---|---|
Insulin resistance biomarkers in small-for-gestational-age infants born to mothers with gestational diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Cohort Studies; Diabetes, Gestational; Female; Fibrinogen; Glucose; Humans; Infant, Newborn; Insulin; Insulin Resistance; Mothers; Pregnancy | 2022 |
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; China; Cholesterol, HDL; Female; Fibrinogen; Glycated Hemoglobin; Hormones; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Uric Acid | 2022 |
Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Pilot Projects; Prolactin; Risk Factors; Uric Acid | 2022 |
Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.
Topics: Alopecia; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Fibrinogen; Humans; Insulin Resistance; Male; Prolactin; Risk Factors; Testosterone; Triglycerides; Uric Acid | 2023 |
Equine insulin dysregulation causes tissue specific alterations of proinflammatory cytokines and acute phase proteins in a NF-kB independent manner.
Topics: Acute-Phase Proteins; Adipose Tissue; Animals; Cytokines; Fibrinogen; Horse Diseases; Horses; Humans; Insulin; Insulin Resistance; Interleukin-6; Metabolic Syndrome; NF-kappa B | 2022 |
Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.
Topics: CD55 Antigens; Cohort Studies; Complement C1q; Complement C3b; Complement Factor B; Complement Factor D; Complement Factor H; Cytokines; Female; Fibrinogen; Humans; Insulin Resistance; Mannose-Binding Lectin; Polycystic Ovary Syndrome; Properdin; Proteomics | 2022 |
Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease.
Topics: C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; COVID-19; Exercise; Fibrinogen; Galectin 3; Humans; Inflammation; Insulin; Insulin Resistance; Leptin; Pandemics; Risk Factors | 2023 |
Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity.
Topics: Aged; Body Mass Index; Cohort Studies; Female; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome | 2023 |
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Fibrinogen; Glycated Hemoglobin; Hashimoto Disease; Humans; Hyperprolactinemia; Insulin Resistance; Lipoproteins, HDL; Prolactin; Risk Factors; Thyroiditis, Autoimmune; Uric Acid | 2023 |
Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
Topics: Androgens; Body Mass Index; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Lisinopril; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid | 2023 |
The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid | 2023 |
Association of Plasma Fibrinogen Level with Insulin Resistance in Angiographically Confirmed Coronary Artery Disease Patients.
Topics: Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Male; Middle Aged; Prognosis; Risk Factors | 2019 |
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Topics: Adult; Aged; Androgens; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; Cardiometabolic Risk Factors; Female; Fibrinogen; Homocysteine; Humans; Hydroxycholecalciferols; Insulin Resistance; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Uric Acid | 2021 |
The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type 2 Diabetes Mellitus.
Topics: Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Insulin Resistance; Machine Learning; Predictive Value of Tests; Retrospective Studies | 2021 |
Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study.
Topics: Age Factors; Aged; Aging; Biomarkers; Blood Coagulation; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Frail Elderly; Frailty; Geriatric Assessment; Humans; Incidence; Inflammation Mediators; Insulin; Insulin Resistance; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Spain; Time Factors | 2017 |
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Triglycerides | 2017 |
Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Chronic Disease; Cross-Sectional Studies; Fatty Acids; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2017 |
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle.
Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Endoplasmic Reticulum Stress; Enzyme Activation; ErbB Receptors; Fibrinogen; Hep G2 Cells; Hepatocytes; Humans; Hyperlipidemias; Inflammation; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Mice, Inbred C57BL; Models, Biological; Muscle, Skeletal; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Phosphorylation; Recombinant Proteins; Transcriptional Activation | 2018 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Decision Support Techniques; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation Mediators; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Predictive Value of Tests; Risk Factors; Up-Regulation; Uric Acid | 2018 |
Febrile neutropenia induces changes in insulin sensitivity similar to obesity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Correlation of Data; Drug Monitoring; Febrile Neutropenia; Female; Fibrinogen; Humans; Infections; Insulin Resistance; Leukemia, Myeloid, Acute; Male; Middle Aged; Obesity; Serbia | 2019 |
The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.
Topics: Adolescent; Anthropometry; Body Mass Index; C-Reactive Protein; Female; Fibrinogen; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome; Waist Circumference | 2018 |
Associations between dietary insulin load with cardiovascular risk factors and inflammatory parameters in elderly men: a cross-sectional study.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Diet; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Iran; Male; Middle Aged; Risk Factors; Triglycerides | 2019 |
Cardiometabolic risk factors in young women with macroprolactinaemia.
Topics: Adult; Cardiovascular Diseases; Cholesterol, LDL; Female; Fibrinogen; Humans; Insulin Resistance; Middle Aged; Prolactin; Risk Factors; Triglycerides; Uric Acid; Young Adult | 2019 |
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Topics: Adult; Alleles; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 1; Fatty Liver; Female; Fibrinogen; Fibrosis; Genetic Variation; Genotype; Humans; Insulin Resistance; Lipase; Liver; Male; Membrane Proteins; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Prospective Studies; Risk Factors | 2013 |
Gamma prime fibrinogen and childhood obesity: ready for prime time?
Topics: Exercise; Female; Fibrinogen; Humans; Insulin Resistance; Life Style; Male; Motor Activity; Obesity | 2013 |
Genetic and environmental factors in associations between infant growth and adult cardiometabolic risk profile in twins.
Topics: Adolescent; Adult; Belgium; Blood Glucose; Blood Pressure; Child, Preschool; Environment; Female; Fibrinogen; Heart Diseases; Humans; Infant; Infant, Newborn; Insulin Resistance; Leptin; Lipids; Male; Metabolic Diseases; Prospective Studies; Risk Factors; Triglycerides; Twins; Twins, Dizygotic; Twins, Monozygotic; Weight Gain | 2013 |
Changes in procoagulants track longitudinally with insulin resistance: findings from the coronary artery risk development in young adults (CARDIA) study.
Topics: Adolescent; Adult; Cohort Studies; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Insulin Resistance; Linear Models; Longitudinal Studies; Male; Risk Factors; von Willebrand Factor; Young Adult | 2014 |
Alcohol drinking patterns and biomarkers of coronary risk in the Spanish population.
Topics: Adult; Aged; Alcohol Drinking; Alcoholic Intoxication; Biomarkers; Blood Glucose; Cholesterol, HDL; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Leptin; Linear Models; Male; Middle Aged; Risk Factors; Spain; Young Adult | 2014 |
Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.
Topics: Adult; Alkaline Phosphatase; Bone Density; C-Reactive Protein; Collagen Type I; Female; Fibrinogen; Gastrectomy; Gastric Bypass; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Osteocalcin; Osteopontin; Peptides; Vitamin D; Weight Loss | 2014 |
Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Inflammation; Insulin Resistance; Iran; Lipids; Liver; Male; Metabolic Syndrome; Middle Aged; Obesity; Vitamin D; Waist Circumference | 2014 |
Inflammation and glycemic tolerance status in pregnancy: the role of maternal adiposity.
Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Ferritins; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leukocyte Count; Obesity; Pregnancy; Risk Factors | 2014 |
Effect of physical activity level on biomarkers of inflammation and insulin resistance over 5 years in outpatients with coronary heart disease (from the Heart and Soul Study).
Topics: Aged; Biomarkers; C-Reactive Protein; California; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Male; Middle Aged; Motor Activity; Outpatients; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Time Factors | 2014 |
The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation.
Topics: Adiponectin; Adolescent; Adult; Biomarkers; Blood Sedimentation; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cognition; Cognition Disorders; Exercise; Female; Fibrinogen; Humans; Immunity, Innate; Inflammation; Insulin Resistance; Intelligence; Middle Aged; Obesity; Young Adult | 2014 |
Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study.
Topics: Adult; Blood Glucose; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Insulin Resistance; Male; Mandibular Advancement; Polysomnography; Prospective Studies; Pulse Wave Analysis; Sleep Apnea, Obstructive; Vascular Stiffness | 2016 |
Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
Topics: Adult; Age Factors; Aged; Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Peptide Hormones; Risk Factors; Waist-Hip Ratio | 2015 |
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.
Topics: Adult; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin Resistance; Phenotype; Polycystic Ovary Syndrome; Risk Assessment; Triglycerides; Young Adult | 2016 |
Effects of kiwi consumption on plasma lipids, fibrinogen and insulin resistance in the context of a normal diet.
Topics: Actinidia; Adult; Aged; Antioxidants; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diet; Female; Fibrinogen; Fruit; Humans; Insulin Resistance; Life Style; Logistic Models; Male; Middle Aged; Motor Activity; Nutrition Assessment; Polyphenols; Surveys and Questionnaires; Triglycerides | 2015 |
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle.
Topics: Animals; Autophagy; Beclin-1; Blood Glucose; Cholesterol; Disease Models, Animal; Fibrinogen; Fructose; Glucose; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Muscle, Skeletal; Suppressor of Cytokine Signaling 3 Protein; Triglycerides | 2017 |
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.
Topics: Aged; Animals; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neoplasm Proteins | 2016 |
Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
Topics: Adolescent; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Logistic Models; Male; Metabolic Syndrome; Overweight; Risk Factors; Socioeconomic Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cystatin C; Drug Administration Schedule; Fasting; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Hypothyroidism; Insulin Resistance; Insulin-Secreting Cells; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Thyroid Neoplasms; Thyroxine; Treatment Outcome; Triglycerides | 2017 |
Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
Topics: Adult; Blood Pressure; C-Reactive Protein; Female; Fibrinogen; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Obesity; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution; Smoking; Turkey | 2009 |
Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Energy Intake; Feeding Behavior; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Surveys and Questionnaires | 2009 |
Effects of hormone replacement therapy on insulin resistance and platelet function tests.
Topics: Adult; Analysis of Variance; Body Weights and Measures; C-Reactive Protein; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Homeostasis; Hormone Replacement Therapy; Humans; Hysterectomy; Insulin Resistance; Middle Aged; Norpregnenes; Platelet Function Tests; Postmenopause; Turkey | 2009 |
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.
Topics: Adult; Aged; Black or African American; Black People; Coronary Artery Disease; Female; Fibrinogen; Glucose; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Risk Factors; White People | 2009 |
Retinal vessel abnormalities are associated with elevated fasting insulin levels and cerebral atrophy in nondiabetic individuals.
Topics: Adult; Aged; Atrophy; Blood Glucose; Blood Pressure; Body Mass Index; Brain; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Photography; Retinal Vessels | 2009 |
Plasma leptin in insulin-resistant and insulin-nonresistant coronary artery disease and its association with cardio-metabolic risk factors among Asian Indians.
Topics: Adult; Asian People; Body Mass Index; Coronary Artery Disease; Female; Fibrinogen; Glucose; Homocysteine; Humans; India; Insulin; Insulin Resistance; Leptin; Lipids; Male; Middle Aged; Risk Factors; Waist Circumference | 2009 |
Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Antifibrinolytic Agents; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydrocortisone; Incidental Findings; Insulin Resistance; Male; Middle Aged; von Willebrand Factor | 2009 |
Relationship between insulin resistance and inflamation markers in hemodialysis patients.
Topics: Albumins; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism; Male; Renal Dialysis; Risk Factors; Urea; Uric Acid | 2010 |
Associations of fibrinogen with metabolic syndrome in rural Chinese population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Fibrinogen; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Regression Analysis; Rural Population; Young Adult | 2010 |
Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.
Topics: Adult; Angiotensin Receptor Antagonists; Biomarkers; Case-Control Studies; Female; Fibrinogen; Fibroblast Growth Factors; Humans; Inflammation; Insulin Resistance; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis | 2010 |
Insulin resistance and acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Obesity | 2010 |
Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels.
Topics: Adolescent; Blood Pressure; Body Weight; Child; Female; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Overweight; Prospective Studies; Thrombin | 2010 |
The relationship between insulin resistance and hypercoagulability in acute ischemic stroke.
Topics: Aged; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Neurologic Examination; Protein C; Protein S; Severity of Illness Index; Statistics as Topic; Stroke; Thrombophilia; von Willebrand Factor | 2010 |
Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes.
Topics: Adult; C-Reactive Protein; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Interleukin-6; Magnesium; Male; Young Adult | 2010 |
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Body Mass Index; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diet; Dietary Carbohydrates; Fatty Acids, Monounsaturated; Female; Fibrinogen; Humans; Insulin Resistance; Life Style; Lipids; Male; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors; Triglycerides | 2010 |
Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.
Topics: Adult; Age Factors; Aged; Body Mass Index; Factor IX; Factor VIII; Factor XI; Factor XII; Fatty Liver; Female; Fibrinogen; Finland; Humans; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Partial Thromboplastin Time; Prothrombin; Sex Factors; von Willebrand Factor | 2011 |
The association between leptin and insulin levels in adults with cystic fibrosis.
Topics: Adult; Area Under Curve; Blood Glucose; Body Mass Index; Canada; Cohort Studies; Cystic Fibrosis; Diabetes Mellitus; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Leptin; Male; Prospective Studies | 2012 |
Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.
Topics: Abdominal Fat; Absorptiometry, Photon; Adult; Blood Coagulation; Blood Coagulation Factors; Body Composition; Body Mass Index; C-Reactive Protein; Factor IX; Factor XI; Factor XII; Fasting; Fatty Liver; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glucose Clamp Technique; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Obesity; Plasminogen Activator Inhibitor 1; Thrombosis; Twins, Monozygotic | 2012 |
Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Topics: Adipokines; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Child; Chitinase-3-Like Protein 1; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Insulin; Insulin Resistance; Lectins; Leukocyte Count; Linear Models; Male; Obesity | 2012 |
Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men.
Topics: Adiposity; Adult; Asia, Southeastern; Asian People; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; California; Cross-Sectional Studies; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Sex Factors; Waist Circumference | 2012 |
Inflammatory and prothrombotic states in obese children of European descent.
Topics: Adipose Tissue; Adolescent; Atherosclerosis; Blood Coagulation Disorders; Child; Cross-Sectional Studies; Cytokines; Europe; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Interleukin-5; Male; Obesity; Prothrombin Time; Switzerland; Thrombin; Thrombosis; White People | 2012 |
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Gonadotropin-Releasing Hormone; Humans; Insulin Resistance; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Triglycerides | 2013 |
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Atherosclerosis; Body Mass Index; Cohort Studies; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Leptin; Male; Metabolic Clearance Rate; Middle Aged; Overweight; Plasminogen Activator Inhibitor 1; Prediabetic State; Prospective Studies; Risk Factors; United States | 2013 |
Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Echocardiography; Fasting; Female; Fibrinogen; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Middle Aged; Odds Ratio; Triglycerides | 2013 |
Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Fibrinogen; Glucose; Homocysteine; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; von Willebrand Factor | 2002 |
PAI-1 in human hypertension: relation to hypertensive groups.
Topics: Adult; Aldosterone; Data Interpretation, Statistical; Female; Fibrinogen; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renin; Sodium Chloride, Dietary | 2002 |
Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibronectins; Humans; Insulin Resistance; Logistic Models; Male; Middle Aged; von Willebrand Factor | 2002 |
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cushing Syndrome; Diabetes Mellitus, Type 2; Diastole; Fasting; Female; Fibrinogen; Glucose Intolerance; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Risk Factors; Systole; Triglycerides; Ultrasonography | 2002 |
C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients.
Topics: Asian People; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homeostasis; Humans; Insulin Resistance; Japan; Lipids; Male; Middle Aged; Thinness | 2002 |
Prevalence and concomitants of glucose intolerance in European obese children and adolescents.
Topics: Adolescent; Birth Weight; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Italy; Lipids; Male; Obesity; Prevalence; Puberty; Risk Factors; Uric Acid | 2003 |
Drink to your health?
Topics: Alcohol Drinking; Beer; Blood Coagulation; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Ethanol; Fibrinogen; Health Promotion; Humans; Insulin Resistance; Wine | 2003 |
[Study on stroke syndrome of Chinese medicine and its relationship with blood hypercoagulative status and insulin resistance in diabetic ischemic stroke patients].
Topics: Aged; Aged, 80 and over; Blood Viscosity; Diabetic Neuropathies; Diagnosis, Differential; Female; Fibrinogen; Humans; Insulin Resistance; Male; Medicine, Chinese Traditional; Middle Aged; Platelet Aggregation; Stroke | 2002 |
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gastroplasty; Humans; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipids; Longitudinal Studies; Male; Middle Aged; Obesity, Morbid; Tumor Necrosis Factor-alpha; Weight Loss | 2003 |
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Topics: Adiponectin; Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Constitution; C-Reactive Protein; Diabetes Mellitus, Type 2; Family; Fasting; Fibrinogen; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Proteins; Reference Values | 2003 |
Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome.
Topics: Adipose Tissue; Adult; Biomarkers; Carboxypeptidase B2; Endothelium, Vascular; Female; Fibrinogen; Humans; Insulin Resistance; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Tissue Distribution | 2003 |
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Topics: Adipose Tissue; Arteriosclerosis; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Risk Factors | 2003 |
Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
Topics: Adult; Climacteric; Diabetes Mellitus, Type 2; Estradiol; Factor VII; Female; Fibrinogen; Follicle Stimulating Hormone; Hemostasis; Humans; Insulin Resistance; Middle Aged; Plasminogen Activator Inhibitor 1; Premenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Tissue Plasminogen Activator | 2003 |
Asymptomatic cerebral lacunae in patients with chronic kidney disease.
Topics: Anemia; Brain Infarction; Carotid Artery Diseases; Chronic Disease; Comorbidity; Creatinine; Electrocardiography; Female; Fibrinogen; Hematocrit; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Kidney Diseases; Kidney Function Tests; Lipoprotein(a); Magnetic Resonance Imaging; Male; Middle Aged; Obesity; Prevalence; Regression Analysis; Risk Factors; Ultrasonography | 2004 |
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides | 2004 |
Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; Cholesterol, LDL; Factor X; Fibrinogen; gamma-Glutamyltransferase; Hemostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Smoking | 2005 |
Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
Topics: Adult; Coronary Disease; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Exercise Test; Fasting; Female; Fibrinogen; Heart Rate; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Sex Characteristics; Smoking | 2005 |
Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
Topics: Adipose Tissue; Aged; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin Resistance; Interleukin-6; Lipids; Middle Aged; Obesity; Postmenopause; Risk | 2005 |
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
Topics: Albuminuria; Blood Pressure; Carotid Arteries; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Exons; Female; Femoral Artery; Fibrinogen; Genotype; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Ultrasonography | 2005 |
Modest lifestyle intervention attenuates the inflammatory state in children.
Topics: Adolescent; Adult; C-Reactive Protein; Child; Exercise; Fibrinogen; Humans; Inflammation; Insulin Resistance; Interleukin-6; Life Style; Obesity; Time Factors | 2005 |
The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity.
Topics: Adult; Blood Glucose; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Fibrinogen; Glycoproteins; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Obesity; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2005 |
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
Topics: Adipose Tissue; Adult; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Endothelium; Fatty Liver; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Tomography, X-Ray Computed; Triglycerides; von Willebrand Factor | 2005 |
The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor alpha; Female; Fibrinogen; Genotype; Haplotypes; Hormone Replacement Therapy; Humans; Insulin Resistance; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Social Class; Waist-Hip Ratio | 2006 |
Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.
Topics: Adipose Tissue; Animals; Blood Glucose; Chromatography, Thin Layer; Diet; Dietary Fats; Energy Metabolism; Fibrinogen; Genotype; Glucose; Glucose Clamp Technique; Insulin Resistance; Interleukin-10; Lipid Metabolism; Lipids; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Serum Amyloid A Protein | 2006 |
Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin.
Topics: Adiposity; Adult; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; von Willebrand Factor | 2006 |
Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study.
Topics: Adult; Analysis of Variance; Biomarkers; Black People; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiac Output; Cardiovascular Physiological Phenomena; Case-Control Studies; Cholesterol, HDL; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leptin; Middle Aged; Obesity; Regression Analysis; South Africa; Triglycerides; Vascular Resistance; Waist-Hip Ratio; White People | 2006 |
Obesity, inflammatory markers and cardiovascular disease: distinguishing causality from confounding.
Topics: Biomarkers; Black People; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Confounding Factors, Epidemiologic; Female; Fibrinogen; Humans; Inflammation Mediators; Insulin Resistance; Leptin; Obesity; White People | 2006 |
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1 | 2006 |
Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Topics: Adiponectin; Adult; Apolipoproteins B; Apoprotein(a); Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Risk Factors | 2006 |
Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Topics: Adult; Androgens; Body Mass Index; Female; Fibrinogen; Hirsutism; Humans; Insulin Resistance; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Waist-Hip Ratio | 2007 |
Aging influences the level and functions of fasting plasma ghrelin levels: the POWIRS-Study.
Topics: Adiponectin; Adult; Age Factors; Aging; Body Mass Index; Fasting; Female; Fibrinogen; Ghrelin; Humans; Hydrocortisone; Insulin Resistance; Middle Aged; Obesity; Peptide Hormones; Thinness | 2007 |
Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.
Topics: Adult; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 2007 |
sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
Topics: Adolescent; Adult; Anthropometry; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Humans; Insulin Resistance; Lipids; Middle Aged; Obesity; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Regression Analysis; Risk Factors; Solubility; von Willebrand Factor | 2008 |
Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
Topics: Adult; Arteries; C-Reactive Protein; Cross-Sectional Studies; Elasticity; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Pulse; Risk Factors; Sex Factors | 2007 |
Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cholesterol; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Statistics, Nonparametric; Triglycerides; Weight Loss | 2007 |
Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance.
Topics: Adult; Blood Viscosity; Body Mass Index; Caloric Restriction; Case-Control Studies; Female; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Obesity, Morbid; Weight Loss | 2007 |
Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Topics: Age Factors; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; India; Inflammation; Insulin Resistance; Male; Middle Aged; Prospective Studies; Risk Factors; Tumor Necrosis Factor-alpha | 2007 |
Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Electrocardiography, Ambulatory; Female; Fibrinogen; Heart Rate; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Male; Risk Factors | 2008 |
Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity.
Topics: Adult; Biomarkers; Blood Coagulation; Cardiovascular Diseases; Fasting; Female; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Male; Risk Factors; Sex Factors; Sleep Wake Disorders; Surveys and Questionnaires | 2008 |
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Topics: Adiponectin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Fatty Liver; Fibrinogen; Humans; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Linear Models; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Triglycerides | 2008 |
Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Disulfides; Female; Fibrinogen; Humans; Insulin Resistance; Malondialdehyde; Nitric Oxide; Oxidative Stress; Polycystic Ovary Syndrome | 2008 |
Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Topics: Adult; Androgens; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Menstruation; Overweight; Polycystic Ovary Syndrome; Progesterone; Vasodilation; Young Adult | 2009 |
Platelet aggregation is not enhanced in patients with prediabetes.
Topics: Adult; Case-Control Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Platelet Aggregation; Prediabetic State | 2007 |
Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
Topics: Adult; Aged; Atherosclerosis; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Vascular Cell Adhesion Molecule-1 | 2009 |
Increased fibrinogen levels in the offspring of hypertensive men. Relation with hyperinsulinemia and the metabolic syndrome.
Topics: Adult; Age Factors; Blood Glucose; Body Mass Index; Cholesterol, HDL; Female; Fibrinogen; Humans; Hypertension; Insulin; Insulin Resistance; Male; Smoking; Syndrome | 1995 |
Hemostatic concomitants of syndrome X.
Topics: Animals; Antigens; Blood Platelets; Cardiovascular Diseases; Epoprostenol; Factor VII; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Microvascular Angina; Models, Biological; Models, Cardiovascular; Plasminogen Activator Inhibitor 1; Risk Factors | 1995 |
[The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, LDL; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged | 1995 |
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Diet, Reducing; Factor VII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Lipids; Obesity; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Tissue Plasminogen Activator | 1995 |
Relationship between hemorrheologic factors and insulin sensitivity in healthy young men.
Topics: Adult; Blood Glucose; Blood Proteins; Blood Viscosity; Catecholamines; Fibrinogen; Hematocrit; Humans; Insulin Resistance; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Reference Values; Sympathetic Nervous System | 1994 |
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Topics: Adult; Aged; Aging; Angina Pectoris; Body Mass Index; Coronary Disease; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; von Willebrand Factor | 1993 |
Insulin resistance and hyperlipoproteinemia in microvascular angina: risk factors or pathogenetic link?
Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Electrocardiography; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged; Risk Factors; Triglycerides | 1995 |
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
Topics: Adult; Diabetes Mellitus, Type 2; Exons; Factor VII; Family Health; Female; Fibrinogen; Genotype; Humans; Insulin Resistance; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; von Willebrand Factor | 1996 |
[Blood viscosity is correlated with insulin resistance].
Topics: Adult; Blood Viscosity; Body Mass Index; Dose-Response Relationship, Drug; Female; Fibrinogen; Glucose Tolerance Test; Hemorheology; Humans; Insulin Resistance; Linear Models; Lipids; Middle Aged; Syndrome | 1996 |
Non-traditional risk factors for atherosclerosis in high risk children.
Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis | 1996 |
The insulin resistance syndrome and postprandial lipid intolerance in smokers.
Topics: Adult; Apolipoprotein A-II; Apolipoproteins B; Blood Glucose; Body Mass Index; C-Peptide; Fibrinogen; Glucose Clamp Technique; Humans; Insulin Resistance; Lipids; Lipoprotein Lipase; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Postprandial Period; Radioimmunoassay; Risk Factors; Smoking; Syndrome; Uric Acid | 1997 |
Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Height; Body Mass Index; Cohort Studies; Female; Fetal Growth Retardation; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Insulin Resistance; Lipids; Male; Risk Factors | 1997 |
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study.
Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol, HDL; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Odds Ratio; Regression Analysis; Social Class; Triglycerides | 1997 |
Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.
Topics: Adult; Anthropometry; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, LDL; Cross-Sectional Studies; Fasting; Fibrinogen; Humans; Insulin; Insulin Resistance; Italy; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Smoking; Triglycerides | 1998 |
Negative correlation between plasma fibrinogen and insulin sensitivity measured with the minimal model technique.
Topics: Adult; Female; Fibrinogen; Hemorheology; Humans; Insulin Resistance; Male; Syndrome | 1998 |
Association between fibrinogen levels and insulin resistance.
Topics: Adult; Body Mass Index; Fatty Acids, Nonesterified; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Male; Reference Values | 1998 |
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity.
Topics: Adult; Belgium; Body Mass Index; Body Weight; Cholesterol; Cholesterol, HDL; Cohort Studies; Comorbidity; Female; Fibrinogen; Follow-Up Studies; Gastroplasty; Humans; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Insulin; Insulin Resistance; Male; Obesity, Morbid; Prevalence; Severity of Illness Index; Triglycerides; Uric Acid; Weight Loss | 1998 |
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Arteriosclerosis; Asian People; Black People; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Regression Analysis; Risk Factors; White People | 1999 |
Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women.
Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Insulin; Insulin Resistance; Leptin; Linear Models; Male; Middle Aged; Obesity; Postmenopause; Premenopause; Proteins; Reference Values; Sex Characteristics; Sex Factors | 1999 |
Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome.
Topics: Adult; Biomarkers; Fasting; Female; Fibrinogen; France; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Sex Characteristics; Smoking; Syndrome; Tissue Plasminogen Activator | 1999 |
Insulin resistance and angiographical characteristics of coronary atherosclerosis.
Topics: Blood Pressure; Coronary Angiography; Coronary Artery Disease; Fibrinogen; Glucose Tolerance Test; Humans; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Regression Analysis; Severity of Illness Index; Uric Acid | 1999 |
Social relations and the metabolic syndrome in middle-aged Swedish women.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Chi-Square Distribution; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hypertension; Insulin Resistance; Life Style; Lipids; Middle Aged; Regression Analysis; Risk Factors; Social Isolation; Social Support; Sweden; Syndrome; von Willebrand Factor | 1999 |
Relationships between fibrinogen and insulin resistance.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Middle Aged; Prognosis; Radioimmunoassay | 2000 |
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Adult; Aged; Arteriosclerosis; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Insulin Resistance; Leukocyte Count; Linear Models; Male; Middle Aged; Risk Factors; Triglycerides | 2000 |
Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.
Topics: Cardiovascular Diseases; Fibrinogen; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Hypopituitarism; Insulin; Insulin Resistance; Obesity; Plasminogen Activator Inhibitor 1; Quality of Life; Recombinant Proteins | 1998 |
Cardiovascular disease in South Asians.
Topics: Asia; Canada; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Lipoprotein(a); Plasminogen Inactivators; Syndrome; Triglycerides | 2000 |
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
Topics: Albuminuria; Arteriosclerosis; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension, Renal; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Nephritis | 2000 |
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.
Topics: Aged; Aged, 80 and over; Antigens; Blood Coagulation; Cardiovascular Diseases; Cluster Analysis; Factor Analysis, Statistical; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors | 2000 |
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes.
Topics: Adolescent; Adult; Albuminuria; Biomarkers; Body Constitution; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Fasting; Fibrinogen; Follow-Up Studies; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Logistic Models; Middle Aged; Risk Factors; Triglycerides; von Willebrand Factor | 2001 |
Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Solubility; Sulfonylurea Compounds; Thrombomodulin; von Willebrand Factor | 2001 |
Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Middle Aged; Models, Biological; Plasminogen Activator Inhibitor 1; Postmenopause; Proinsulin; Risk Factors; Triglycerides | 2001 |
Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease.
Topics: Adult; Age of Onset; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Insulin Resistance; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides | 2001 |
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Base Sequence; DNA Primers; Fibrinogen; Glucose Tolerance Test; Hydroxysteroid Dehydrogenases; Insulin Resistance; Lipids; Lipoproteins; Liver; Mice; Mice, Knockout; Transcription, Genetic | 2001 |
The relation of body fat mass and distribution to markers of chronic inflammation.
Topics: Adipose Tissue; Adult; Aged; Arteriosclerosis; Biomarkers; Body Composition; Body Constitution; Body Mass Index; C-Reactive Protein; Carotid Arteries; Chronic Disease; Cross-Sectional Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Sex Factors | 2001 |
Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance?
Topics: Adult; Biomarkers; Blood Glucose; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Aggregation; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Hemorheology; Homeostasis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Lipids; Male; Multivariate Analysis; Risk Factors | 2001 |
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Topics: Acute-Phase Proteins; Arteriosclerosis; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Ethnicity; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Incidence; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Regression Analysis; Smoking; United States | 2002 |
Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
Topics: Adult; Coronary Disease; Family; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Insulin Resistance; Male; Middle Aged; Regression Analysis; Tissue Plasminogen Activator | 2002 |
Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; HIV Infections; HIV Protease Inhibitors; Humans; Insulin Resistance; Lipids; Lipodystrophy; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors | 2002 |
Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.
Topics: Asia, Southeastern; Coronary Thrombosis; Female; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Male; Middle Aged; Random Allocation; Risk Factors; Stroke; Tissue Plasminogen Activator; von Willebrand Factor | 2002 |
The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adult population.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Age Factors; Aged; Blood Pressure; Body Weight; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Hip; Humans; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Risk Factors; Triglycerides | 1992 |
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors.
Topics: Blood Glucose; C-Peptide; Cholesterol; Cholesterol, LDL; Fibrinogen; Humans; Hypertension; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pilot Projects; Plasminogen Inactivators; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 1991 |
Metabolic effects in children of a 37 amino acid fragment of bovine growth hormone.
Topics: Adenoma, Chromophobe; Adolescent; Alkaline Phosphatase; Amino Acids; Blood Urea Nitrogen; Calcium; Child; Child, Preschool; Craniopharyngioma; Creatine; Dwarfism; Female; Fibrinogen; Growth Disorders; Growth Hormone; Humans; Hypopituitarism; Insulin Resistance; Male; Uric Acid | 1973 |